Get the Stockscreener App
4.85
4.30%
0.20
After Hours:
4.91
0.06
+1.24%
Neuraxis Inc stock is traded at $4.85, with a volume of 137.81K.
It is up +4.30% in the last 24 hours and down -5.83% over the past month.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
See More
Previous Close:
$4.65
Open:
$4.5
24h Volume:
137.81K
Relative Volume:
0.41
Market Cap:
$51.67M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-6.0129
EPS:
-0.8066
Net Cash Flow:
-
1W Performance:
+11.49%
1M Performance:
-5.83%
6M Performance:
+94.78%
1Y Performance:
+104.64%
1-Day Range:
$4.50
$5.1414
1-Week Range:
$4.31
$5.1414
52-Week Range:
$1.33
$6.20
Neuraxis Inc Stock (NRXS) Company Profile
Name
Neuraxis Inc
Sector
Industry
Phone
(812) 689-0791
Address
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
4.85 | 49.54M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Neuraxis Inc Stock (NRXS) Latest News
Bear Alert: Can NeurAxis Inc expand its profit marginsJuly 2025 News Drivers & Community Consensus Stock Picks - baoquankhu1.vn
Bond Watch: Is ADC Therapeutics SA a stock for growth or value investorsGDP Growth & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Short Squeeze: Is NeurAxis Inc stock risky to hold nowWeekly Volume Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Surprises Report: Is NeurAxis Inc exposed to political riskJuly 2025 EndofMonth & Safe Entry Zone Tips - baoquankhu1.vn
Earnings Update: Is HLMN stock trending bullishNew Guidance & Momentum Based Trading Ideas - baoquankhu1.vn
Aug Sectors: Is BWBBP stock a good pick for beginnersEarnings Summary Report & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Loss Report: Is NeurAxis Inc a speculative investmentJuly 2025 Reactions & Reliable Volume Spike Alerts - baoquankhu1.vn
Wall Street Recap: Is NeurAxis Inc impacted by rising ratesRisk Management & Accurate Trade Setup Notifications - baoquankhu1.vn
Can NeurAxis Inc. expand its profit marginsQuarterly Profit Report & AI Enhanced Execution Alerts - mfd.ru
Aug Technicals: Will NeurAxis Inc. stock hit new highs in YEARBond Market & Consistent Profit Trading Strategies - mfd.ru
Quarterly Earnings: Does NeurAxis Inc have pricing powerEarnings Risk Report & Accurate Entry/Exit Alerts - baoquankhu1.vn
Is MAZE a cyclical or defensive stockMarket Performance Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
How does KVH Industries Inc score in quality rankingsQuarterly Market Review & High Win Rate Trade Alerts - baoquankhu1.vn
CEO Change: Will NeurAxis Inc benefit from current market trends2025 Price Momentum & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Short Squeeze: Is NeurAxis Inc trading at a discountJuly 2025 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
Trade Recap: Can NeurAxis Inc outperform under higher oil pricesOil Prices & Free Verified High Yield Trade Plans - baoquankhu1.vn
Income Plays: Will NeurAxis Inc stock hit new highs in YEARQuarterly Portfolio Report & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
NRXS: New CPT code and expanded coverage drive growth for a non-drug GI therapy with strong margins - TradingView
NRXS: Expanded insurance coverage and CPT code position for high-margin growth in pediatric GI therapy - TradingView — Track All Markets
Aug Summary: What momentum indicators show for NeurAxis Inc stockPrice Action & High Accuracy Investment Signals - Bộ Nội Vụ
How NeurAxis Inc stock reacts to oil pricesJuly 2025 Trade Ideas & Growth Focused Stock Pick Reports - Bộ Nội Vụ
Neuraxis achieves medical coverage policy milestone for PENFS - MSN
Returns Recap: Should I buy WEC Energy Group Inc stock now2025 Key Highlights & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Why NeurAxis Inc. stock could outperform in 2025Short Setup & Verified Momentum Stock Watchlist - Улправда
How NeurAxis Inc. stock reacts to global recession fearsQuarterly Portfolio Report & Stepwise Swing Trade Plans - Улправда
Heera Ispat Limited Sees Spike in Bullish Option FlowDay Trading Setups & Free Discover Dynamic Stocks - bollywoodhelpline.com
Why NeurAxis Inc. stock is popular among millennialsQuarterly Investment Review & AI Driven Stock Reports - ulpravda.ru
Why Immsi S.p.A. (IMY) stock attracts HNW investorsJuly 2025 PostEarnings & Low Risk High Reward Ideas - Улправда
Why Bluejay Diagnostics Inc. stock remains a top recommendationJuly 2025 Setups & Technical Pattern Alert System - Улправда
How rising interest rates impact NeurAxis Inc. stockEarnings Beat & AI Forecasted Stock Moves - Улправда
Is NeurAxis Inc. stock a safe haven assetMarket Sentiment Summary & Proven Capital Preservation Tips - ulpravda.ru
Will Neuraxis Inc. stock sustain dividend payoutsMarket Rally & AI Driven Stock Movement Reports - Улправда
NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway - Yahoo Finance
The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis - Zacks Investment Research
Top Stock Reports for Meta, Bank of America & Procter & Gamble - Yahoo Finance
Aug PreEarnings: Can NeurAxis Inc stock double in next 5 years2025 Geopolitical Influence & Verified Trade Idea Suggestions - moha.gov.vn
Glenmark Will Innovation PayMarket Sentiment Indicators & Double Or Triple Capital - Bollywood Helpline
Neuraxis Inc. (NRXS) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
Candlestick Reversal Detected on Universal Cables Limited’s ChartMarket Sentiment Shifts & Small Budget Wealth Tips - bollywoodhelpline.com
Portfolio Recap: Can NeurAxis Inc stock weather global recessionQuarterly Investment Review & Stepwise Trade Execution Plans - moha.gov.vn
NeurAxis (NASDAQ:NRXS) Director Gil Aharon Purchases 286,138 Shares - Defense World
NeurAxis Insider Makes Bold Multi-Million Move in the Market - TipRanks
Neuraxis Insider Bought Shares Worth $1,007,206, According to a Recent SEC Filing - marketscreener.com
Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN
Craig-Hallum Maintains NeurAxis (NRXS) Buy Recommendation - Nasdaq
Aug Volume: Is NeurAxis Inc stock a safe haven assetM&A Rumor & Risk Controlled Daily Plans - moha.gov.vn
NRXS: Craig-Hallum Raises Price Target to $8.00, Maintains Buy R - GuruFocus
NeurAxis Expands VA Network and Secures Significant Coverage - timothysykes.com
Analyst Downgrade: What technical patterns form on Unith Ltd CM30 stock chartsWeekly Trade Analysis & Community Trade Idea Sharing Platform - moha.gov.vn
NeurAxis Expands Healthcare Reach with New VA and Insurance Agreements - StocksToTrade
NeurAxis Secures Major Health Insurance Coverages - timothysykes.com
Neuraxis Inc Stock (NRXS) Financials Data
There is no financial data for Neuraxis Inc (NRXS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Cap:
|
Volume (24h):